Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03090165
Title Ribociclib and Bicalutamide in AR+ TNBC
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Ruth O'Regan, M.D.

triple-receptor negative breast cancer


Bicalutamide + Ribociclib

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.